rs200241993
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000260.4(MYO7A):āc.614T>Cā(p.Ile205Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000762 in 1,613,982 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I205V) has been classified as Likely benign.
Frequency
Consequence
NM_000260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7A | NM_000260.4 | c.614T>C | p.Ile205Thr | missense_variant | 7/49 | ENST00000409709.9 | NP_000251.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.614T>C | p.Ile205Thr | missense_variant | 7/49 | 1 | NM_000260.4 | ENSP00000386331 | ||
MYO7A | ENST00000458637.6 | c.614T>C | p.Ile205Thr | missense_variant | 7/49 | 1 | ENSP00000392185 | P1 | ||
MYO7A | ENST00000409619.6 | c.581T>C | p.Ile194Thr | missense_variant | 8/50 | 1 | ENSP00000386635 |
Frequencies
GnomAD3 genomes AF: 0.000407 AC: 62AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000963 AC: 24AN: 249160Hom.: 0 AF XY: 0.0000814 AC XY: 11AN XY: 135188
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461648Hom.: 0 Cov.: 32 AF XY: 0.0000385 AC XY: 28AN XY: 727104
GnomAD4 genome AF: 0.000407 AC: 62AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.000430 AC XY: 32AN XY: 74482
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | MYO7A: PM2, PP3 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 28, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 25, 2018 | The p.Ile205Thr variant in MYO7A has not been previously reported in individuals with hearing loss, but has been identified in 0.13% (32/24016) of African chrom osomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute. org; dbSNP rs200241993). Although this variant has been identified in the genera l population, its frequency is not high enough to rule out a pathogenic role. Co mputational prediction tools and conservation analysis suggest that this variant may impact the protein, though this information is not predictive enough to det ermine pathogenicity. In summary, the clinical significance of the p.Ile205Thr v ariant is uncertain. ACMG/AMP Criteria applied: PP3. - |
Usher syndrome type 1B Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 24, 2020 | - - |
Retinal dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Blueprint Genetics | Feb 20, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at